About Smith & Nephew plc (SN)
Smith & Nephew plc is a Medical Devices company operating in the Healthcare sector.
SN trades on the London Stock Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- £1,107.50
- Market Cap
- £9.27B
- 52-Week High
- £1,426.59
- 52-Week Low
- £980.40
- Sector
- Healthcare
- Industry
- Medical Devices
£1,000 Invested in Smith & Nephew plc (SN)
How much would £1,000 invested in SN be worth today?
What would £1,000 invested in SN 1 year ago be worth today?
A £1,000 investment in Smith & Nephew plc (SN) in 2025 would be worth £794 as of November 2026, representing a -20.6% total return.
What would £1,000 invested in SN 3 years ago be worth today?
A £1,000 investment in Smith & Nephew plc (SN) in 2023 would be worth £1,129 as of November 2026, representing a +12.9% total return.
What would £1,000 invested in SN 5 years ago be worth today?
A £1,000 investment in Smith & Nephew plc (SN) in 2021 would be worth £875 as of November 2026, representing a -12.5% total return.
What would £1,000 invested in SN 10 years ago be worth today?
A £1,000 investment in Smith & Nephew plc (SN) in 2016 would be worth £978 as of November 2026, representing a -2.2% total return.
What would £1,000 invested in SN at IPO be worth today?
A £1,000 investment in Smith & Nephew plc (SN) at IPO would be worth £6,630 as of November 2026, representing a +563.0% total return.
Monthly Returns Heatmap
Over the past 38+ years (459 months), Smith & Nephew plc (SN) has averaged a monthly return of +0.66% with a median return of +0.00%. The stock had 215 positive months (47%) and 215 negative months (47%). The best month in SN's history was June 2000 with a +37.1% return, while the worst was March 2020 at -17.5%. Historically, December tends to be the strongest month (averaging +2.9%), and March the weakest (-1.7%).
SN's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 5 consecutive months of losses. The best full year was 2009 with a cumulative return of +42.1%, and the worst was 1990 at -20.9%.
Annual Returns
Over 38 years of trading history, Smith & Nephew plc (SN) has delivered an average annual return of +6.94% with a median return of +2.67%. The compound annual growth rate (CAGR) is +5.59%. The stock posted gains in 24 years (63%) and losses in 14 years (37%).
SN's best year was 2009 with a +45.86% gain, while the worst was 2008 at -24.39%. The longest streak of consecutive positive years was 8, and the longest losing streak was 5 years. SN achieved double-digit gains (10%+) in 14 years. It suffered double-digit losses in 6 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -10.55% | £1,238.18 | £1,107.50 |
| 2025 | +24.95% | £990.90 | £1,238.18 |
| 2024 | -8.05% | £1,077.66 | £990.90 |
| 2023 | -2.77% | £1,108.32 | £1,077.66 |
| 2022 | -14.20% | £1,291.77 | £1,108.32 |
| 2021 | -14.32% | £1,507.68 | £1,291.77 |
| 2020 | -17.58% | £1,829.30 | £1,507.68 |
| 2019 | +25.19% | £1,461.19 | £1,829.30 |
| 2018 | +13.69% | £1,285.27 | £1,461.19 |
| 2017 | +5.51% | £1,218.19 | £1,285.27 |
| 2016 | +1.10% | £1,204.99 | £1,218.19 |
| 2015 | +1.70% | £1,184.83 | £1,204.99 |
| 2014 | +38.00% | £858.55 | £1,184.83 |
| 2013 | +26.74% | £677.41 | £858.55 |
| 2012 | +8.66% | £623.45 | £677.41 |
| 2011 | -7.52% | £674.17 | £623.45 |
| 2010 | +5.80% | £637.20 | £674.17 |
| 2009 | +45.86% | £436.85 | £637.20 |
| 2008 | -24.39% | £577.75 | £436.85 |
| 2007 | +8.83% | £530.88 | £577.75 |
| 2006 | -0.46% | £533.31 | £530.88 |
| 2005 | +0.48% | £530.77 | £533.31 |
| 2004 | +13.60% | £467.24 | £530.77 |
| 2003 | +23.34% | £378.83 | £467.24 |
| 2002 | -8.41% | £413.63 | £378.83 |
| 2001 | +34.05% | £308.56 | £413.63 |
| 2000 | +22.27% | £252.35 | £308.56 |
| 1999 | +11.27% | £226.79 | £252.35 |
| 1998 | +3.64% | £218.83 | £226.79 |
| 1997 | -0.24% | £219.36 | £218.83 |
| 1996 | -3.08% | £226.33 | £219.36 |
| 1995 | +28.16% | £176.60 | £226.33 |
| 1994 | +0.03% | £176.54 | £176.60 |
| 1993 | +0.03% | £176.48 | £176.54 |
| 1992 | -3.19% | £182.29 | £176.48 |
| 1991 | +33.39% | £136.66 | £182.29 |
| 1990 | -20.77% | £172.49 | £136.66 |
| 1989 | +22.84% | £140.41 | £172.49 |
Frequently Asked Questions: SN
What sector is SN in? ▼
SN operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has SN performed historically? ▼
Over 38 years of trading history, SN has posted gains in 24 years (63% of the time). The best year was 2009 with a +45.9% return. Past performance does not guarantee future results.
How can I invest in SN? ▼
You can invest in SN through any brokerage account that offers access to the London Stock Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold SN.
Last updated: 11/1/2026